Search results
Psoriasis: Features That May Affect Biologic Rx Outcomes
Medscape· 6 days agoSeveral clinical characteristics were negatively associated with responses to biologics in a...
11 Best Hair Growth Supplements for Women Over 50 To Reverse Thinning Hair No Matter the Cause
First for Women via Yahoo News· 4 days agoIt's truly amazing how upping your intake of vitamins C and E (found in this supplement) can make a...
Psoriasis study shows high level of arthritis symptoms in patients
Medical Xpress· 6 days agoThe study led by researchers at the Universities of Oxford, University College Dublin and supported...
Certain Clinical Factors Tied to Poor Response to Biologics for Psoriasis
MedPage Today· 6 days agoPrevious exposure to biologics, higher BMI, smoking all negatively linked to response
13 Best Shampoos for Thinning Hair, According to Hair and Skin Experts
Prevention via AOL· 4 days agoWe reviewed the best shampoos for thinning hair, per dermatologists. Our top picks reign from brands...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks via Yahoo Finance· 5 days agoAbbVie ABBV announced that the FDA has granted approval to its blockbuster drug, Skyrizi to treat...
FDA Approves Skyrizi for Ulcerative Colitis
Medscape· 5 days agoThe approval is the fourth indication for the anti–interleukin 23 monoclonal antibody after approval for Crohn's disease, psoriatic arthritis, and plaque...
Central Bank & Trust Co. Has $609,000 Holdings in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 7 hours agoCentral Bank & Trust Co. decreased its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 2.0% during the first quarter, according to its most recent filing with the Securities and Exchange ...
Psoriatic Arthritis Drugs Comparably Improve Joint Outcomes
Medscape· 5 days agoReal-world study data suggest there is little difference among five drug classes commonly used to ...
In a 'gold rush' for treating bowel disease, AbbVie clears one more stage
Crain s Chicago Business· 5 days agoWith the arrival of biosimilar competition for its blockbuster drug Humira, AbbVie has said much of its sales growth potential lies with these two anti-inflammatories. In April, the North Chicago ...